JP2024502948A5 - - Google Patents
Info
- Publication number
- JP2024502948A5 JP2024502948A5 JP2023538794A JP2023538794A JP2024502948A5 JP 2024502948 A5 JP2024502948 A5 JP 2024502948A5 JP 2023538794 A JP2023538794 A JP 2023538794A JP 2023538794 A JP2023538794 A JP 2023538794A JP 2024502948 A5 JP2024502948 A5 JP 2024502948A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- cells
- saturated
- therapeutic
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163139730P | 2021-01-20 | 2021-01-20 | |
| US63/139,730 | 2021-01-20 | ||
| PCT/US2022/012867 WO2022159421A1 (en) | 2021-01-20 | 2022-01-19 | Ionizable lipids for nanomaterials |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502948A JP2024502948A (ja) | 2024-01-24 |
| JP2024502948A5 true JP2024502948A5 (enExample) | 2025-01-24 |
Family
ID=82549646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023538794A Pending JP2024502948A (ja) | 2021-01-20 | 2022-01-19 | ナノ材料のためのイオン化可能な脂質 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230348359A1 (enExample) |
| EP (1) | EP4281114A4 (enExample) |
| JP (1) | JP2024502948A (enExample) |
| CN (1) | CN116782951A (enExample) |
| AU (1) | AU2022210299A1 (enExample) |
| CA (1) | CA3203784A1 (enExample) |
| WO (1) | WO2022159421A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3145913A1 (en) | 2019-07-29 | 2021-02-04 | James Everett Dahlman | Nanomaterials containing constrained lipids and uses thereof |
| IL294318A (en) | 2020-01-09 | 2022-08-01 | Guide Therapeutics Llc | Nanomaterials |
| EP4281080A4 (en) | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025035202A1 (en) * | 2023-08-04 | 2025-02-20 | Nanovation Therapeutics Inc. | Ionizable lipids comprising macrocyclic rings for the delivery of therapeutic agents |
| AU2024325364A1 (en) * | 2023-08-16 | 2026-03-26 | Beam Therapeutics Inc. | Ionizable lipids with branched head groups |
| WO2025137243A1 (en) * | 2023-12-19 | 2025-06-26 | Amplitude Therapeutics, Inc. | Methods for measuring self-amplifying rna and trans amplifying rna activity in vivo |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20181541A1 (es) * | 2011-10-27 | 2018-09-26 | Massachusetts Inst Technology | Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco |
| JP6136226B2 (ja) * | 2012-12-10 | 2017-05-31 | コニカミノルタ株式会社 | 光学フィルムのロール体とその製造方法、包装体、偏光板および液晶表示装置 |
| JP2017500865A (ja) * | 2013-12-19 | 2017-01-12 | ノバルティス アーゲー | レプチンｍＲＮＡの組成物および製剤 |
| EP3083556B1 (en) * | 2013-12-19 | 2019-12-25 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
-
2022
- 2022-01-19 CA CA3203784A patent/CA3203784A1/en active Pending
- 2022-01-19 CN CN202280008627.4A patent/CN116782951A/zh active Pending
- 2022-01-19 EP EP22743057.6A patent/EP4281114A4/en active Pending
- 2022-01-19 AU AU2022210299A patent/AU2022210299A1/en active Pending
- 2022-01-19 JP JP2023538794A patent/JP2024502948A/ja active Pending
- 2022-01-19 WO PCT/US2022/012867 patent/WO2022159421A1/en not_active Ceased
-
2023
- 2023-07-12 US US18/220,874 patent/US20230348359A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024502948A5 (enExample) | ||
| JP2024505449A5 (enExample) | ||
| JP2024503441A5 (enExample) | ||
| JP2024502954A5 (enExample) | ||
| JP2025501731A5 (enExample) | ||
| JP2025500824A5 (enExample) | ||
| JP7638972B2 (ja) | 治療薬の細胞内送達のための分岐状尾部脂質化合物及び組成物 | |
| CN112789031A (zh) | 用于核酸递送的包含脂化的阳离子肽化合物的脂质纳米颗粒制剂 | |
| JP2022536495A5 (enExample) | ||
| CN117440834A (zh) | 核糖核酸的体内递送用组合物及其制备方法 | |
| JP2024503976A5 (enExample) | ||
| CN118307423A (zh) | 一种可电离寡聚物材料、含其的载药纳米胶束及其应用 | |
| US20240247109A1 (en) | Multi-motif dendrons and their supramolecular structures and uses thereof | |
| Zhu et al. | One‐Component Ionizable Amphiphilic Janus Dendrimers for Targeted mRNA Delivery | |
| TWI876778B (zh) | 用於傳遞核酸的基於環烷的脂質化合物以及包括其之脂質奈米粒子 | |
| EP4644379A1 (en) | Lipid compound and lipid nanoparticle composition | |
| US20260085081A1 (en) | Phosphatidylamine compounds including a plurality of tertiary amino group structures and compositions thereof | |
| JP2026501351A (ja) | 組成物 | |
| JP2018070555A (ja) | 皮膚線維症処置剤 | |
| CN1845746A (zh) | 单独包含去纤苷酸或与其它抗肿瘤剂联合的抗肿瘤制剂 | |
| Gao et al. | Engineering a spleen-selective mRNA-LNPs vaccine by decoupling the inflammation from cellular immunity-mediated cancer immunotherapy | |
| KR101239492B1 (ko) | 폴리소르비톨계 삼투압적 활성 전달체 및 이를 이용한 유전자 치료 | |
| JP2025525597A (ja) | アミノ脂質化合物、その製造方法およびその利用 | |
| KR20240167649A (ko) | 아미노 지질 화합물, 이의 제조 방법, 이의 조성물 및 이의 용도 | |
| JP4808403B2 (ja) | リン脂質誘導体 |